"消化管（胃・小腸・大腸）の内視鏡検査・治療や造影検査、特に大腸がん、 ポリープ、炎症性腸疾患（潰瘍性大腸炎・クローン病）の診断・治療を得意分野とし、 検査機器や治療には、大きな病院の診療レベルと同等にするよう最新のものを取り入れています。 また、地元で診療を重ねた医院として、各医療機関と連携した豊かなネットワークがございますので、ご心配ごとはお気軽にご相談下さい。 （診療開始は、朝8時30分から。土曜日も午後3時まで診療しています。駐車場20台）"

During the past decade, Takagi Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Takagi Clinic" are "Ulcerative Colitis" (3 trials), "Crohn's Disease" (2 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Takagi Clinic" in a lesser frequency.

Most popular intervention types in "Takagi Clinic" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Mirikizumab" (3 trials), "Golimumab" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Takagi Clinic" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Takagi Clinic". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Takagi Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Takagi Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".